Grants and Contributions:
Title:
Delivery platform ready for the first-in-human trials
Agreement Number:
1014276
Agreement Value:
$260,000.00
Agreement Date:
Jan 2, 2024 - Sep 30, 2024
Description:
The project will focus on finalizing the design of the catheter delivery platform for the firm's implant, to prepare the firm's mitral valve repair system for the human trials stage.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5Y 3W2
Reference Number:
172-2023-2024-Q4-1014276
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
740269121
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Jul 17, 2024
Recipient's Legal Name:
Vesalius Cardiovascular Inc.
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911
Amendments: